ArticleJournal of medical imaging (Bellingham, Wash.)2023
4D digital anthropomorphic breast phantom for iodinated contrast-enhanced imaging.
Article in Journal of medical imaging (Bellingham, Wash.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Differentiating between benign and malignant masses is one of the biggest challenges in breast imaging. The challenge is ingrained in the similarity of the attenuation coefficients between different types of lesion tissues and fibroglandular tissues. Contrast-enhanced imaging techniques can take advantage of the differing metabolism in different tissues, therefore, potentially allowing better differentiation of malignant and benign lesions. To facilitate the development and optimization of such technologies, we propose a fully digital 4D phantom that features time-varying enhancement patterns for different tissue types. Approach: The 4D model is based on a static, anthropomorphic 3D digital breast phantom. Masses inserted into the 3D phantom are based on a previously published model. Physiological parameters that capture the key characteristics of masses, e.g., wash-in and wash-out rates indicating metabolic level, are employed in the model to simulate fundamental features for categorizing mass types. The two-compartmental model, a well-known model in the field of pharmacokinetics, is used to depict the diffusion process of the contrast agent. Two methods are proposed to allow for the simulations of lesions with necrotic cores of varying shapes and sizes. Results: The fourth dimension of the phantom models different time-varying enhancement patterns for different materials including fibroglandular tissue and lesion tissue. Metabolic characteristics of mass models can be adjusted to provide different enhancement patterns. The parameters of the 4D phantom can also be adjusted to fit different scenarios. The usage of the phantom is demonstrated by simulating mammograms at different time frames. Conclusion: A 4D digital anthropomorphic breast phantom that models different time-varying contrast enhancement patterns is presented. This phantom could be an integral tool for use in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.